Technology

NASAL VACCINES

  • Potential best-in-class vaccination
  • Painless
  • Non-invasive
  • Suitable for all ages
  • No hazardous waste
  • Generates immunity where needed
  • Multi-array antigen-presenting and Th2 cell mimetic
  • Compensating for reduced CD4+ cells
  • Double-action stimulating:
    • Antigen presenting cells
    • B cells
  • Potential therapeutic as well as prophylactic vaccines
  • Potential safety advantages

ORAL VACCINES

  • Oral vaccine to generate greater immunity than injectable approaches for the important mucosal surfaces
  • More convenient to take (oral, easy-to-swallow)
  • Easier to distribute globally
  • Lower burden to healthcare systems (self-administration potential)
  • No hazardous waste
  • Potential safety advantages

RAPID ULTRASENSITIVE HOME SELF-TESTING

  • Ultrasensitive biosensor
  • Screening multiple viruses/antibodies
  • Rapid point-of-care diagnostic
  • Self-administered testing
  • Readily adaptable to new virus variants
  • Mobile-enabled accessible surveillance
  • Rapid manufacturing
  • Low cost of volume manufacturing
  • Stability reducing logistics costs